Nobilamides A-H, Long-Acting Transient Receptor Potential Vanilloid-1 (TRPV1) Antagonists from Mollusk-Associated Bacteria

被引:32
作者
Lin, Zhenjian [1 ]
Reilly, Christopher A. [2 ]
Antemano, Rowena [4 ]
Hughen, Ronald W. [3 ]
Marett, Lenny [1 ]
Concepcion, Gisela P. [4 ]
Haygood, Margo G. [5 ]
Olivera, Baldomero M. [6 ]
Light, Alan [3 ]
Schmidt, Eric W. [1 ,6 ]
机构
[1] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Anesthesiol, Salt Lake City, UT 84112 USA
[4] Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines
[5] Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Environm & Biomol Syst, Beaverton, OR 97006 USA
[6] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA
关键词
CAPSAICIN RECEPTOR; ION-CHANNEL; CELL-DEATH; EPITHELIAL-CELLS; ACTIVATION; SENSITIZE; CYSTEINE; TL-119; ACIDS;
D O I
10.1021/jm101621u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New compounds nobilamides A-H and related known compounds A-3302-A and A-3302-B were isolated based upon their suppression of capsaicin-induced calcium uptake in a mouse dorsal root ganglion primary cell culture assay. Two of these compounds, nobilamide B and A-3302-A, were shown to be long-acting antagonists of mouse and human TRPV1 channels, abolishing activity for >1 h after removal of drug presumably via a covalent attachment. Other derivatives also inhibited the TRPV1 channel, albeit with low potency, affording a structure-activity profile to support the proposed mechanism of action. While the activities were modest, we propose a new mechanism of action and a new site of binding for these inhibitors that may spur development of related analogues for treatment of pain.
引用
收藏
页码:3746 / 3755
页数:10
相关论文
共 50 条
  • [21] Discovery of Novel 5,5-Diarylpentadienamides as Orally Available Transient Receptor Potential Vanilloid 1 (TRPV1) Antagonists
    Saku, Osamu
    Ishida, Hiroshi
    Atsumi, Eri
    Sugimoto, Yoshiyuki
    Kodaira, Hiroshi
    Kato, Yoshimitsu
    Shirakura, Shiro
    Nakasato, Yoshisuke
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3436 - 3451
  • [22] β-Arrestin-2 Desensitizes the Transient Receptor Potential Vanilloid 1 (TRPV1) Channel
    Por, Elaine D.
    Bierbower, Sonya M.
    Berg, Kelly A.
    Gomez, Ruben
    Akopian, Armen N.
    Wetsel, William C.
    Jeske, Nathaniel A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (44) : 37552 - 37563
  • [23] Identification and Quantification of Transient Receptor Potential Vanilloid 1 (TRPV1) in Equine Articular Tissue
    vom Braucke, Anne Franck Gallagher
    Frederiksen, Nanna Lysemose
    Berg, Lise Charlotte
    Aarsvold, Stacie
    Mueller, Felix Christoph
    Boesen, Mikael Ploug
    Lindegaard, Casper
    ANIMALS, 2020, 10 (03):
  • [24] Involvement of Transient Receptor Potential Cation Channel Vanilloid 1 (TRPV1) in Myoblast Fusion
    Kurosaka, Mitsutoshi
    Ogura, Yuji
    Funabashi, Toshiya
    Akema, Tatsuo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (10) : 2275 - 2285
  • [25] Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress
    Sappington, Rebecca M.
    Sidorova, Tatiana
    Ward, Nicholas J.
    Chakravarthy, Rohini
    Ho, Karen W.
    Calkins, David J.
    CHANNELS, 2015, 9 (02) : 102 - 113
  • [26] Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks
    Wong, Gilbert Y.
    Gavva, Narender R.
    BRAIN RESEARCH REVIEWS, 2009, 60 (01) : 267 - 277
  • [27] Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels
    Aguiar, D. C.
    Moreira, F. A.
    Terzian, A. L.
    Fogaca, M. V.
    Lisboa, S. F.
    Wotjak, C. T.
    Guimaraes, F. S.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 46 : 418 - 428
  • [28] Pharmacology of Modality-Specific Transient Receptor Potential Vanilloid-1 Antagonists That Do Not Alter Body Temperature
    Reilly, Regina M.
    McDonald, Heath A.
    Puttfarcken, Pamela S.
    Joshi, Shailen K.
    Lewis, LaGeisha
    Pai, Madhavi
    Franklin, Pamela H.
    Segreti, Jason A.
    Neelands, Torben R.
    Han, Ping
    Chen, Jun
    Mantyh, Patrick W.
    Ghilardi, Joseph R.
    Turner, Teresa M.
    Voight, Eric A.
    Daanen, Jerome F.
    Schmidt, Robert G.
    Gomtsyan, Arthur
    Kort, Michael E.
    Faltynek, Connie R.
    Kym, Philip R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (02) : 416 - 428
  • [29] Increased Transient Receptor Potential Vanilloid Type 1 (TRPV1) Signaling in Idiopathic Overactive Bladder Urothelial Cells
    Li, Mingkai
    Sun, Yan
    Simard, J. Marc
    Chai, Toby C.
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (04) : 606 - 611
  • [30] Dopamine modulation of transient receptor potential vanilloid type 1 (TRPV1) receptor in dorsal root ganglia neurons
    Chakraborty, Saikat
    Rebecchi, Mario
    Kaczocha, Martin
    Puopolo, Michelino
    JOURNAL OF PHYSIOLOGY-LONDON, 2016, 594 (06): : 1627 - 1642